APR 01, 2015 7:24 AM PDT

Why Slimy Cheats Don't Win, and Other Amoeba Tales

WRITTEN BY: Judy O'Rourke
Darwin's evolutionary theory predicts survival of the fittest. So why do different survival tactics coexist, if evolution should always favor the winning strategy?

To answer that question scientists at the Universities of Bath and Manchester, UK, have been studying a single-celled amoeba, also known as slime mold, which displays certain behaviors that have been labelled as "cheating" or "cooperating."
Amoeba working together to form a fruiting body.
In a study, published in the journal Current Biology, the team found that cheaters don't necessarily win in terms of overall survival, suggesting that biologists should re-evaluate how they define and measure social cooperation.

Their research has medical implications when it comes to developing therapies that use socially successful bacteria to fight diseases such as lung infections.

"If the cheats always win, then according to Darwin, altruism shouldn't exist," says professor Chris Thompson, Manchester's faculty of Life Sciences. "To study this we looked at why the single fittest strategy in the amoeba community doesn't dominate."

The team looked at how amoebae compete against each other during cooperative encounters. These strange microbes generally live in the soil as single cells, eating bacteria, but when food is limited, they clump together to form a ‘slug' that moves to a different location before transforming into a fruiting body which eventually releases spores to produce the next generation of amoebae.

Development into a fruiting body requires cooperation, with some of the amoebae forming the stalk part of the fruiting body, effectively sacrificing themselves for the benefit of the ones that become spores. Therefore biologists have labelled the individuals that become the stalk as ‘altruists', with the individuals that tend to form lots of spores being identified as ‘cheats' because they benefit disproportionately.

However, the scientists from Bath and Manchester found that these assumptions don't necessarily tell the whole story. Those labelled as cheats don't end up having higher success than those that appear to lose since the cheats pay a price for their apparent success by producing larger numbers of lower quality spores. These inferior spores have lower survival rates, so overall the number of spores that survive is similar to those amoebae who ‘cooperate'.

"Our study shows that whilst there are definitely winners and losers in social cooperation, you can't measure social success just by counting the number of spores these molds produce," says professor Jason Wolf, University of Bath's Department of Biology & Biochemistry. Those that produce lots of spores often make inferior ones that don't have any overall advantage over their competitors.

"Basically we need to look at the bigger picture when measuring social success, rather than making assumptions based on measuring the wrong things," he says.

"What our study says is that when we look at systems through just one aspect then that system can appear to be unbalanced and shouldn't work, but in reality we are a collection of many features that together determine our success, and so our variety helps to make us more equal," Thompson says. "Our study threw up quite a big surprise because the way we measure fitness in a system is currently misleading. By focusing on the number of offspring (in this case spores) rather than the quality, we're using an incorrect measurement of success. What we thought of as socially successful needs to be re-evaluated."

The paper, "Fitness trade-offs result in the illusion of social success," will be published in Current Biology on April 20, 2015. The paper was published online on the journal's website on March 26.

[Source: University of Manchester]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
JAN 08, 2020
Cell & Molecular Biology
JAN 08, 2020
In a First, Scientists Generate Early Human Immune Cells in the Lab
Now we know more about the early stages of the human immune system....
JAN 20, 2020
Neuroscience
JAN 20, 2020
Ovarian Cancer Protein Accelerates Alzheimer's Neurodegeneration
Around 21,000 people in the US are diagnosed with ovarian cancer every year, while an estimated 5.8 million Americans have Alzheimer’s. Now, research...
JAN 26, 2020
Cell & Molecular Biology
JAN 26, 2020
Using Stem Cells to Treat Chronic Pain
Scientists have used a mouse model to show that human stem cells could be used to engineer neurons that stop pain....
FEB 03, 2020
Cell & Molecular Biology
FEB 03, 2020
Brain Organoids May Not be Living Up to the Hype
Cells can be grown in special ways to create three-dimensional, miniature models of organs. But how good are they?...
FEB 10, 2020
Cell & Molecular Biology
FEB 10, 2020
Lighting a Path to an Alzheimer's Disease Treatment
Alzheimer's impacts millions of people around the world; globally, it is thought to cost $605 billion a year, and there is still no way to treat it....
FEB 23, 2020
Cell & Molecular Biology
FEB 23, 2020
A New Class of Bacterial Enzymes is Discovered
Bacterial enzymes can serve many processes, from breaking down pollutants and digesting foods to metabolizing drugs....
Loading Comments...